Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01013350 · ClinicalTrials.gov registry record

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials

A clinical trial, sponsored by EMD Serono.

Completed
Registry status
1,161
Enrollment target

NCT01013350 is a clinical trial that has completed, run by EMD Serono. The registered enrollment target is 1,161 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01013350 has completed, sponsored by EMD Serono.

COMPLETED
Registry status
1,161 participants
Enrollment target

Study Summary

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants who Have Participated in Cladribine Clinical Trials

Trial Details

FieldValue
Enrollment Target 1,161 participants
Start Date 2009-11-30
Est. Completion 2018-10-25

Sponsor

EMD Serono

71 total trials

What the Registry Record Tells You About NCT01013350

The ClinicalTrials.gov registry entry for NCT01013350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01013350 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01013350 about?

NCT01013350 is a clinical study titled "Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials". Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants who Have Participated in Cladribine Clinical Trials

What is the current status of trial NCT01013350?

This trial is currently completed. The enrollment target is 1,161 participants. The study started on 2009-11-30. Estimated completion is 2018-10-25.

Who is sponsoring clinical trial NCT01013350?

This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.